Clinical trials
Retinitis Pigmentosa trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 4 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Active, not recruiting | 5 |
| Recruiting | 4 |
| Withdrawn | 2 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Okuvision GmbH | 4 |
| QLT Inc. | 3 |
| Retina Implant AG | 3 |
| Columbia University | 2 |
| Jaeb Center for Health Research | 2 |
| Laboratoires Thea | 2 |
| STZ eyetrial | 2 |
| Science Corporation | 2 |
| Second Sight Medical Products | 2 |
| University Hospital Tuebingen | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Retinitis Pigmentosa | 30 |
| Eye Diseases | 6 |
| Eye Diseases, Hereditary | 5 |
| Retinal Diseases | 5 |
| Usher Syndromes | 5 |
| Retinal Degeneration | 4 |
| Cone-Rod Dystrophies | 3 |
| Leber Congenital Amaurosis | 3 |
| Blindness | 2 |
| Choroideremia | 2 |
Trials
Showing 51 to 30 of 30. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.